haloperidol has been researched along with Hypercholesterolemia in 4 studies
Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.
Hypercholesterolemia: A condition with abnormally high levels of CHOLESTEROL in the blood. It is defined as a cholesterol value exceeding the 95th percentile for the population.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The authors' goal was to assess the effects of clozapine, olanzapine, risperidone, and haloperidol on glucose and cholesterol levels in hospitalized patients with schizophrenia or schizoaffective disorder during a randomized double-blind 14-week trial." | 5.10 | Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics. ( Chakos, M; Citrome, L; Cooper, TB; Czobor, P; Lieberman, JA; Lindenmayer, JP; McEvoy, JP; Sheitman, B; Volavka, J, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lindenmayer, JP | 1 |
| Czobor, P | 1 |
| Volavka, J | 1 |
| Citrome, L | 1 |
| Sheitman, B | 1 |
| McEvoy, JP | 1 |
| Cooper, TB | 1 |
| Chakos, M | 1 |
| Lieberman, JA | 1 |
| Rice, E | 1 |
| Makuku, S | 1 |
| Shafique, M | 1 |
| Khan, IA | 1 |
| Akhtar, MH | 1 |
| Hussain, I | 1 |
| Pundir, CS | 1 |
| Narang, J | 1 |
| Chauhan, N | 1 |
| Sharma, P | 1 |
| Sharma, R | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Outcome Evaluation of Solutions for Wellness and Team Solutions Program in Patients With Severe Mental Illness[NCT00661869] | 295 participants (Actual) | Interventional | 2006-09-30 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for haloperidol and Hypercholesterolemia
| Article | Year |
|---|---|
Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics.
Topics: Adult; Aged; Antipsychotic Agents; Benzodiazepines; Blood Glucose; Cholesterol; Clozapine; Double-Bl | 2003 |
3 other studies available for haloperidol and Hypercholesterolemia
| Article | Year |
|---|---|
Role of cholesterol in the distribution of haloperidol and trifluoperazine in blood and plasma.
Topics: Blood Cells; Blood Proteins; Cholesterol; Cholesterol Esters; Haloperidol; Humans; Hypercholesterole | 1981 |
Serum lipids and lipoproteins in schizophrenic patients receiving major tranquilizers.
Topics: Adult; Chlorpromazine; Cholesterol; Drug Therapy, Combination; Female; Haloperidol; Humans; Hypercho | 1988 |
An amperometric cholesterol biosensor based on epoxy resin membrane bound cholesterol oxidase.
Topics: Biosensing Techniques; Cholesterol Oxidase; Diagnostic Techniques, Cardiovascular; Electrodes; Enzym | 2012 |